Thermo Fisher Scientific (TMO) Short term Debt (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Short term Debt for 18 consecutive years, with $3.1 billion the latest figure, recorded in Q1 2026.

• Short term Debt for Q1 2026 came in at $3.1 billion, up 9.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 9.61% YoY), and the FY2025 annual result was $3.5 billion, up 59.58% from the prior year.
• Short term Debt was $3.1 billion for Q1 2026 at Thermo Fisher Scientific, down from $3.5 billion in the prior quarter.
• Over five years, Short term Debt peaked at $6.1 billion in Q2 2023 and troughed at $1.0 billion in Q3 2022.
• Average Short term Debt over 5 years is $3.5 billion, with a median of $3.6 billion recorded in 2023.
• Year-over-year, Short term Debt soared 46550.0% in 2022 and sank 56.77% in 2025.
• Over 5 years, Short term Debt stood at $5.6 billion in 2022, then slumped by 35.31% to $3.6 billion in 2023, then sank by 38.65% to $2.2 billion in 2024, then soared by 59.58% to $3.5 billion in 2025, then decreased by 12.54% to $3.1 billion in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $3.1 billion in Q1 2026, $3.5 billion in Q4 2025, and $3.8 billion in Q3 2025.